Anti-tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy

Sleep

Volumn 33, Issue 7, 2010, Pages 869-874

  Kawashima, Minae ^a   Lin, Ling ^a   Tanaka, Susumu ^b   Jennum, Poul ^c   Knudsen, Stine ^c   Nevsimalova, Sona ^d   Plazzi, Giuseppe ^e   Mignot, Emmanuel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d CHARLES UNIVERSITY   (Czech Republic)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Anti streptolysin O (ASO); Autoantibody; Human narcolepsy; Tribbles homolog 2 (TRIB2)

Indexed keywords

ANTISTREPTOLYSIN; AUTOANTIBODY; HLA DQB1 ANTIGEN; PROTEIN; PROTEIN TRIB2; TRIB2 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGE; ANTIBODY DETECTION; ARTICLE; BODY MASS; CATAPLEXY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NARCOLEPSY; PRIORITY JOURNAL;

EID: 77954369866     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.1093/sleep/33.7.869     Document Type: Article

References (30)

1. Mignot E, Lin L, Rogers W, et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 2001;68:686-99.
2. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40.
3. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002;59:1553-62.
4. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-7.
5. Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999;98:365-76.
6. Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999;98:437-51.
7. Scammell TE. The frustrating and mostly fruitless search for an autoimmune cause of narcolepsy. Sleep 2006;29:601-2.
8. Hallmayer J, Faraco J, Lin L, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 2009;41:708-11.
9. Cvetkovic-Lopes V, Bayer L, Dorsaz S, et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest 2010;120:713-9.
10. Zhang Y, Davis JL, Li W. Identification of tribbles homolog 2 as an autoantigen in autoimmune uveitis by phage display. Mol Immunol 2005;42:1275-81.
11. Kimura M, Tatsumi K, Tada H, et al. Anti-CYP2D6 antibodies detected by quantitative radioligand assay and relation to antibodies to liver-specific arginase in patients with autoimmune hepatitis. Clinica Chimica Acta 2002;316:155-64.
12. Kerkar N, Ma Y, Hussain M, et al. A novel assay for detecting antibodies to cytochrome P4502D6, the molecular target of liver kidney microsomal antibody type 1. J Immunol Methods 1999;223:227-35.
13. American Academy of Sleep Medicine. International Classification of Sleep Disorders, 2nd ed, Diagnostic & Coding Manual: Westchester, IL, 2005.
14. Hong SC, Lin L, Jeong JH, et al. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness. Sleep 2006;29:1429-38.
15. Bourgin P, Zeitzer JM, Mignot E. CSF hypocretin-1 assessment in sleep and neurological disorders. Lancet Neurol 2008;7:649-62.
16. Tanaka S, Honda Y, Inoue Y, Honda M. Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy. Sleep 2006;29:633-8. (Pubitemid 43752927)
17. Todd EW. Antigenic streptococcal hemolysin. J Exp Med 1932;55:267-80.
18. Aran A, Lin L, Nevsimalova S, et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 2009;32:979-83.
19. Kraemer HC. Evaluating Medical Tests. SAGE Publications Inc. 1992.
20. Toyoda H, Tanaka S, Miyagawa T, Honda Y, Tokunaga K, Honda M. Anti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy. Sleep 2010;33:875-878.
21. Mahler M, Fritzler MJ. Epitope specificity and significance in systemic autoimmune diseases. Ann N Y Acad Sci 2010;1183:267-87.
22. Castro C, Gourley M. Diagnostic testing and interpretation of tests for autoimmunity. J Allergy Clin Immunol 2010;125:S238-47.
23. Bingley PJ. Clinical applications of diabetes antibody testing. J Clin Endocrinol Metab 2010;95:25-33.
24. Koepsell T, Longstreth W, Ton T. Medical exposures in youth and the frequency of narcolepsy with cataplexy: a population-based case-control study in genetically predisposed people. J Sleep Res 2010;19:80-6.
25. Sfriso P, Ghirardello A, Botsios C, et al. Infections and autoimmunity: the multifaceted relationship. J Leukoc Biol 2010;87:385-95.
26. Agrawal RV, Murthy S, Sangwan V, Biswas J. Current approach in diagnosis and management of anterior uveitis. Indian J Ophthalmol 2010;58:11-9.
27. Tanaka S, Honda M. IgG abnormality in narcolepsy and idiopathic hypersomnia. PLoS One 2010;5:e9555.
28. Honda M, Eriksson KS, Zhang S, et al. IGFBP3 colocalizes with and regulates hypocretin (orexin). PLoS One 2009;4:e4254.
29. Overeem S, Black JL 3rd, Lammers GJ. Narcolepsy: immunological aspects. Sleep Med Rev 2008;12:95-107.
30. Jackson MW, Spencer NJ, Reed JH, Smith AJ, Gordon TP. Potentiation of a functional autoantibody in narcolepsy by a cholinesterase inhibitor. Lab Invest 2009;89:1332-9.